acetylsalicylic acid is one of 1059 small molecule programs targeting Insulin resistance. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1931 competitors in COVID-19
acetylsalicylic acid
COVID-19 Vaccine
Proventil
SARS-COV-2 VACCINE
Statin
Interferon-Gamma
Antihypertensive Agents
Exoflo
Other Tkis
Covid Infection
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources